Jana Pachlopnik Schmid

Author

University Children's Hospital Zurich ORCID

Also Known As

Andreas Neubauer, David Martino, J M Pachlopnik, J Pachlopnik, J Pachlopnik Schmid, J SCHMID, J Schmid, J. P. Schmid, J. Pachlopnik, J. Pachlopnik Schmid

145

Publications

6.2K

Citations

H-Index

Concepts

All Affiliations

University Children's Hospital Zurich University of Zurich Inserm University of Freiburg Hôpital Necker-Enfants Malades

About

Jana Pachlopnik Schmid is an author at University Children's Hospital Zurich specializing in immunology, medicine, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	20	1.5K
2	Allergy	4	4	554
3	Public Health	3	3	83
4	Cell Biology	1	1	55
5	Clinical Immunology	1	1	423

Jana Pachlopnik Schmid

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative Angelo Ravelli, Francesca Minoia, Sergio Davì, Arthritis & Rheumatology	2015	742
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects Charlotte Schwab, Annemarie Gabrysch, Peter Olbrich, Journal of Allergy and Clinical Immunology Clinical ImmunologyAllergyLymphocyte DevelopmentMedicineImmunodeficiencies	2018	423
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis Angelo Ravelli, Francesca Minoia, Sergio Davì, Annals of the Rheumatic Diseases	2016	380
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency) Jana Pachlopnik Schmid, Danielle Canioni, Despina Moshous, Blood	2010	364
X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease Claire Booth, Kimberly Gilmour, Paul Veys, Blood	2010	309
MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival Nadine T. Nehme, Jana Pachlopnik Schmid, Franck Debeurme, Blood	2011	278
The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry Nienke M. ter Haar, Jerold Jeyaratnam, Helen J. Lachmann, Arthritis & Rheumatology	2016	215
Neutralization of IFNγ defeats haemophagocytosis in LCMV‐infected perforin‐ and Rab27a‐deficient mice Jana Pachlopnik Schmid, Chen‐H. Ho, Fabrice Chrétien, EMBO Molecular Medicine	2009	189
The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis Sebastian Bode, Sandra Ammann, Waleed Al–Herz, Haematologica	2015	187
Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry Maria Elena Maccari, Hassan Abolhassani, Asghar Aghamohammadi, Frontiers in Immunology	2018	176

Page 1